Conselho Nacional de Desenvolvimento Científico e Tecnológico / CHAPTER II: The snake venom is composed by a diversity of biomolecules with many actions on physiological processes. The serine peptidases are a group of proteases present in the constitution of the venom, capable of interfering on several points of hemostasis. Some serine peptidases has thrombin-like activity, what makes them targets on the development of therapeutics agentes on the treatment of many hemostatic disorders. In this study, a recombinant thrombin-like serine peptidase called rBpSP-II was obtained from the cDNA of the venom gland of the snake Bothrops pauloensis and biochemically characterized. The cDNA correspondent to rBpSP-II was cloned on the pPICZαA vector and inserted on the methylotrophic yeast Pichia pastoris KM71H for the heterologous expression. This enzyme showed single band when analised on SDS-PAGE with approximated molecular mass of 44,5 kDa under reducing conditions. The enzyme rBpSP-II showed clotting activity on bovine plasma and proteolytic activity on fibrinogen, cleaving exclusively the Aα chain. The evaluation of rBpSP-II activity on chromogenic substrates showed that the enzyme has thrombin-like activity due to its capacity to hydrolyze the thrombin substrate. / CAPÍTULO II: A peçonha de serpente é composta por uma diversidade de biomoléculas com inúmeras ações sobre os processos fisiológicos. As serinoproteases são um grupo de proteases presentes na constituição da peçonha, capazes de interferir em diversos pontos da hemostasia. Algumas serinoproteases possuem atividade semelhante à trombina, o que as tornam alvos de interesse no desenvolvimento de agentes terapêuticos no tratamento de desordens hemostáticas. Neste estudo, uma serinoprotease thrombin-like recombinante denominada rBpSP-II foi obtida a partir do cDNA da glândula da peçonha da serpente Bothrops pauloensis e caracterizada bioquimicamente. O cDNA correspondente à rBpSP-II foi clonado no vetor pPICZαA e inserido na levedura metilotrófica Pichia pastoris KM71H para a realização da expressão heteróloga. Esta enzima apresentou banda única quando analisada em SDS-PAGE com massa molecular aproximada de 44.5 kDa sob condições redutoras. A rBpSP-II apresentou atividade coagulante sobre plasma bovino e atividade proteolítica sobre o fibrinogênio, clivando preferencialmente a cadeia Aα. A avaliação da atividade da rBpSP-II sobre substratos cromogênicos demonstrou que a enzima possui atividade thrombin-like devido a sua capacidade de hidrolisar o substrato da trombina. / Mestre em Genética e Bioquímica

A proteína serina/treonina fosfatase do tipo 1 (PP1) é a principal serina/treonina fosfatase envolvida na regulação de diversos processos tais como metabolismo, crescimento e divisão celular, síntese protéica e processamento de RNA. A holoenzima PP1 é constituída de uma subunidade catalítica conservada (PP1c) e subunidades reguladoras variáveis. Em mamíferos já foram identificados dezenas de polipeptídeos que associam-se direta ou indiretamente a PP1c, gerando holoenzimas com localizações celulares e especificidades distintas. Entre as proteínas que se associam a PP1c, muitas têm função inibitória como o inibidor-1 (I-1) e o inibidor-2 (I-2). A partir de extratos de micélios de Neurospora crassa foi purificada uma proteína, denominada INc-1, que atua in vitro como inibidor da atividade de fosforilase fosfatase de PP1c e constitui-se no primeiro exemplo de subunidade reguladora da PP1 descrito em fungos filamentosos. INc-1 apresenta diversas características bioquímicas comuns ao I-2 de mamíferos. Seqüências parciais de aminoácidos de três fragmentos proteolíticos obtidos de INc-1 permitiram a identificação de uma ORF (fase aberta de leitura) no genoma de N. crassa que provavelmente codifica INc-1. A análise dessa ORF mostrou que a sequência de aminoácidos do INc-1 é similar a do I-2, especialmente em regiões supostamente envolvidas em sua interação com a PP1c. Neste trabalho descrevemos a clonagem e a expressão em bactérias da sequência codificadora de INc-1. A atividade inibidora de PP1c de duas isoformas recombinantes purificadas, INc-1L e INc-1, foram avaliadas e comparadas. A forma denominada INc-1L apresenta em sua região aminoterminal um segmento de 38 aminoácidos derivado da retenção de um íntron, sem alterar a fase de leitura. Ambas proteínas recombinantes exibiram efeito inibidor sobre a atividade de fosforilase fosfatase de PP1c recombinante, sendo que a IC50 determinada para INc-1L foi de ~50nM e para INc-1 foi de ~11nM, sugerindo que a retenção do segmento de aminoácidos codificado pelo íntron na isoforma INc-1L diminui seu potencial inibitório. Verificamos também que o mRNA de INc-1 é expresso durante o crescimento vegetativo de N.crassa, apresentando níveis máximos na fase exponencial. / Type 1 protein serine/threonine phosphatases (PP1) play important roles in the regulation of many cellular functions including metabolism, cell growth and division, protein synthesis and pre-mRNA splicing. PP1 holoenzyme consists of one highly conserved catalytic subunit (PP1c) and variable regulatory subunits. A number of proteins that interact with PP1c have been described in mammals and the respective holoenzymes present distinct substrate specificity and/or different subcelular localization. Among the proteins that interact with PP1c, there are many with inhibitory effect such as inhibitor-1 (I-1) and inhibitor-2 (1-2). It has been demonstrated that a protein denominated INc-1, purified from Neurospora crassa extracts, specifically inhibits PP1c and has biochemical properties that resemble those of mammalian I-2. INc-1 is the first example of a PP1c regulatory subunit in filamentous fungi. Partial amino acid sequences of INc-1 led to the identification of an ORF (open reading frame) in Neurospora crassa genome which appears to encode INc-1. This ORF shows similarity with mammalian I-2 mainly in regions mapped as sites for interaction with PP1c. In this work we report the cloning and bacterial expression of the coding sequence for INc-1. The PP1c inhibitory activities of two recombinant isoforms, named INc-1L and INc-1, were compared. INc-1L aminoacid sequence presents an in frame segment of 38 residues encoded by an non-processed intron. 80th recombinant proteins showed inhibitory effect against phosphorylase phosphatase activity of recombinant PP1c, with IC50 of ~50nM for INc-1L and ~11nM for INc-1, suggesting that retention of the 38 residue segment decrease the inhibitory potential of INc-1L. We have also verified that INc-1 mRNA is expressed during N.crassa vegetative growth with maximum level at the exponential phase.

Submitted by Biblioteca da Faculdade de Farmácia (bff@ndc.uff.br) on 2018-03-12T17:36:57Z No. of bitstreams: 1 PEDRO HENRIQUE RODRIGUES DE ALENCAR AZEVEDO.pdf: 15048741 bytes, checksum: a121d29e5dc4898c7b8e4a85def01e12 (MD5) / Made available in DSpace on 2018-03-12T17:36:57Z (GMT). No. of bitstreams: 1 PEDRO HENRIQUE RODRIGUES DE ALENCAR AZEVEDO.pdf: 15048741 bytes, checksum: a121d29e5dc4898c7b8e4a85def01e12 (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / As calicreínas teciduais humanas (KLKs) compreendem uma família de 15 enzimas serina proteases (KLKs 1-15) amplamente encontradas nos tecidos humanos. Em diversas patologias como a dermatite atópica, psoríase, síndrome de Netherton, câncer de ovário, mama e testículos, as KLKs encontram-se em concentrações elevadas. Por exemplo, as KLKs 5 e 7 estão mais abundantemente expressadas na pele, na qual estão envolvidas com o processo de descamação da mesma, e também presentes em alguns tipos de carcinomas. Dessa forma, as KLKs 5 e 7 são consideradas importantes alvos terapêuticos para o tratamento de doenças onde elas encontram-se superexpressadas, enfatizando a existência de somente um fármaco comercialmente disponível como inibidor de KLK. Nesse contexto, o trabalho descreve a síntese de 3 séries de compostos peptideomiméticos, incorporando o cerne estatina e diferentes resíduos de aminoácidos, planejados como candidatos a inibidores das enzimas serina proteases do KLKs 5 e 7. Os compostos finais foram obtidos utilizando uma rota sintética eficiente tendo como reação-chave a formação da ligação peptídica entre o cerne estatina e cloridratos de aminoésteres, previamente sintetizados. Os compostos sintetizados foram identificados por técnicas de Ressonância Magnética Nuclear, Infravermelho e Espectrometria de massas de alta resolução e os produtos finais serão avaliados em testes in vitro de inibição das enzimas KLKs / Human tissue kallikreins (KLKs) comprise a family of 15 serine protease enzymes (KLKs 1-15) widely found in human tissues. In several pathologies such as atopic dermatitis, psoriasis, Netherton syndrome, ovarian, breast and testis cancer, KLKs are in high concentrations. For example, KLKs 5 and 7 are more abundantly expressed in the skin, in which they are involved in the desquamation process, and also present in some types of carcinomas. Thus, KLKs 5 and 7 are considered important therapeutic targets for the treatment of diseases where they are over expressed, emphasizing the existence of only one commercially available drug as a KLK inhibitor. In this context, the work describes the synthesis of three series of peptideomimetic compounds incorporating the statin core and different amino acid residues, designed as candidates for inhibitors of the serine protease enzymes of KLKs 5 and 7. The final compounds were obtained using an efficient synthetic route based on the reaction of formation of the peptide bond between the statin core and previously synthesized amino acid hydrochlorides. The synthesized compounds were identified by Nuclear Magnetic Resonance, Infrared and High Resolution Mass Spectrometry techniques and the final products will be evaluated in in vitro inhibition assays of the KLKs enzymes

Orientador: Sergio Marangoni, Luis Alberto Ponce Soto / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-12T15:27:30Z (GMT). No. of bitstreams: 1 VilcaQuispe_Augusto_M.pdf: 840674 bytes, checksum: 0ee3f83d8486d73f628e60ca5c8a83fd (MD5) Previous issue date: 2008 / Resumo: Muitas das toxinas isoladas e estudadas em seus efeitos biológicos precisam ser reavaliadas à luz de metodologias otimizadas em HPLC e confirmadas por espectrometria de massas, devido à possível presença de algum componente não estudado. No caso da serpente Bothrops marajoensis, são valorizados os estudos sobre essa espécie devido aos poucos trabalhos realizados, provavelmente por se tratar de uma espécie restrita e rara encontrada na ilha de Marajó, no Pará, e posteriormente em alguns locais litorâneos do Maranhão, aparentemente endêmica. A reprodutibilidade da atividade biológica, através dos efeitos farmacológicos, só é possível com a utilização de frações quimicamente homogêneas que mantenham a integridade da função biológica. No presente trabalho, foi purificada uma nova serinoprotease TLBm, com atividade trombina "like" em um único passo cromatográfico em um sistema de HPLC de fase reversa, com um alto grau de pureza e homogeneidade molecular, sem perda da atividade biológica. A nova serinoprotease foi caracterizada fisico-quimicamente, revelando uma massa molecular de 33332,5 Da por Espectrometria de Massa (MALDI-Tof). Por outro lado, mostrou uma atividade proteolítica perante o substrato cromogênico DL-BA?NA, assim como foi capaz de evidenciar uma atividade fibrinogenolítica frente ao fibrinogênio bovino e hidrolisar a cadeia alfa (a) e beta (ß), comportando-se como uma trombina "like" tipo A e B. Os estudos da atividade cinética mostraram que a serinoprotease com atividade trombina "like" possui um comportamento michaeliano frente ao substrato DL-BA?NA, registrando as constantes cinéticas de Vmax = 2,3x10-1 nmoles p-NA/Lt/min e o KM = 0,52x10-1M. Os estudos do efeito da temperatura sobre a atividade catalítica revelaram que a serinoprotease TLBm apresenta uma ótima atividade em torno de 38ºC e um pH de 8,0. Para confirmar o caráter trombina "like" da TLBm, esta foi inibida pela ação do fenilmetilsulfonil fluoreto (PMSF) e outros inibidores, através dos quais a atividade foi reduzida em mais de 50% (69,89±1,5 %). A análise de composição de aminoácidos mostrou que a serinoprotease TLBm trata-se de uma proteína de caráter ácido ao apresentar um elevado número de aminoácidos ácidos, assim como uma boa quantidade de aminoácidos hidrofóbicos, o que garante a estabilidade conformacional da proteína. A presença de 12 cisteínas sugere a possível presença de 6 pontes dissulfeto. A seqüência N-terminal da serinoprotease com atividade trombina "like" TLBm mostrou um alto grau de homologia seqüencial (55,9 a 79,4 %). No entanto, existem algumas substituições nos aminoácidos (S)12?(H)12 e (V)15?(L)15, os quais poderiam estar relacionados à diferença na atividade biológica estudada aqui ou em outras atividades, o que faria da TLBm uma serinoprotease particular. Com relação ao estudo das atividades biológicas, a TLBm mostrou-se desprovida de atividade hemorrágica, o que é característico desta família de proteínas e reforça a afirmação de esta ser uma serinoprotease. A TLBm apresentou também baixa capacidade inflamatória (edematogênica) e uma alta concentração na letalidade (DL50) intracerebroventricular (i.c.v), evidenciando que a toxina não contribui significativamente com a letalidade do veneno total. A serinoprotease com atividade trombina "like" TLBm tem a propriedade de induzir a agregação plaquetária em plasma rico em plaquetas (PRP) e esse efeito é inibido na presença do PMSF. / Abstract: Many of the isolated and studied toxins in their biological effects need to be revalued, to the light of methodologies optimized in HPLC and confirmed by Mass Spectrometry, due to the possible presence of some component which has not been studied. In the case of the serpent Bothrops marajoensis, its results are valuable due to the fact that there are few works accomplished probably because the treating of a restricted and rare species found at the island of Marajó, in Pará, and later in some coastal places of Maranhão, which seem endemic. The reproduction of the biological activity, through the pharmacological effects, is only possible with the use of chemically homogeneous fractions so that they maintain the integrity of the biological function. In the present work a new serineprotease was purified with activity thrombin like TLBm in a Chromatography step in a system of HPLC of reverse phase, with a high degree of purity and molecular homogeneity, without loss of the biological activity. A new serineprotease was characterized physical-chemically revealing a molecular mass of 33332,5 Da by a Mass Spectrometry (MALDI-Tof), on the other hand, it did show an proteolitic activity before the substratum chromogenic DL-BA?NA, as well as it was capable to evidence an fibrinogenolitic activity in front of the bovine fibrinogen, and hydrolise the alpha (a) and beta (ß) chain which behaved as a thrombin like A and B types. The studies of the kinetic activity showed that the serineprotease with activity thrombin like, possesses a michaeliano behavior in front of the substratum DL-Ba?NA registering the kinetic constants of Vmax = 2,3x10-1 nmoles ?-NA/Lt/min and the KM = 0,52x10-1M respectively. The studies of the effect of the temperature under the catalytic activity, revealed that the serineprotease TLBm was capable to show a great activity around 38ºC and a pH of 8,0. To confirm the character thrombin like of TLBm, it was inhibited by the action of the fenilmetilsulfonil fluoride (PMSF) and other inhibitors, where the activity was reduced in more of the 50% (69,89 ± 1,5%). The analysis of composition of amino acids showed that the serineprotease TLBm is a character protein acid when presenting a high number of acid amino acids, as well as a good amount of amino acids hydrophobic that guarantees the conformational stability of the protein. The presence of 12 cisteinas suggests the possible presence of 6 dissulfeto bridges. The N-terminal sequence of the serineprotease with activity thrombin like TLBm, showed a high degree of sequential homology (55,9 to 79,4%). However there are some substitutions in the following amino acids: (S)12?(H)12 and (V)15?(L)15 which could be related with the difference in the biological activity studied here or with other activities, which would make TLBm a private serineprotease. The studies of biological activity such an as hemorrhage, reveal that the serineprotease is completely deprived which is known is already of this family of proteins. On the other hand the studies of the inflammatory effect (oedematogenic) reveal that the serineprotease possesses a low inflammatory capacity and finally it displays a high concentration in the lethality (DL50) intracerebroventricular (i.c.v.) showing that the toxin doesn't contribute significantly with the lethality of the total poison. The serineprotease with thrombin like activity has the property of inducing the platelet aggregation in platelets-rich plasma (PRP), and that effect is inhibited in the presences of the PMSF. / Mestrado / Bioquimica / Mestre em Biologia Funcional e Molecular

A resistência aos antibióticos adquirida por micro-organismos patogênicos é um problema de saúde mundial e, por isso, o desenvolvimento de novos agentes antimicrobianos vem sendo amplamente estimulado. Sabendo que muitos peptídeos bioativos correspondem a fragmentos peptídicos de proteínas e/ou seus análogos, este trabalho teve o objetivo de desenvolver novos peptídeos antimicrobianos (AMPs) a partir das sequências aminoacídicas e das estruturas 3D de proteínas possivelmente envolvidas na atividade antimicrobiana de venenos de serpentes pouco estudados. As etapas iniciais seguidas foram: a) escolher uma fosfolipase A2 (PLA2) de veneno de serpente peruana do gênero Bothrops da família Viperidae com sequência de aminoácidos conhecida e modelar por homologia a sua estrutura 3D; b) verificar atividade antimicrobiana em venenos de serpentes peruanas dos gêneros Bothrops e Bothriopsis da família Viperidae, selecionar um veneno ativo, fracioná-lo para isolar proteínas provavelmente envolvidas nessa atividade, tripsinizar as proteínas isoladas, sequenciar os fragmentos trípticos para identificá-las, localizar esses fragmentos em sequências aminoacídicas de proteínas com estruturas 3D disponíveis correlatas às proteínas isoladas/identificadas em classe, função e fonte natural. Em seguida, foram escolhidos fragmentos peptídicos da PLA2 (item a) e das proteínas isoladas do veneno ativo (item b) e/ou desenhados análogos que apresentassem características exibidas por AMPs conhecidos. Os peptídeos desenhados foram sintetizados, purificados, caracterizados e testados em suas atividades antimicrobianas. Os modelos estruturais 3D da PLA2 de Bothrops pictus e quatro peptídeos (PLA2-1 a -4) amidados derivados dela foram obtidos, sendo o PLA2-1 ativo frente a Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Candida krusei e Candida parapsilosis (MICs de 6,25-200 µmol.mL-1). Dos três venenos de serpentes peruanas testados, Bothrops taeniatta, Bothrops barnetti e Bothriopsis oligolepis, os dois últimos inibiram o crescimento de S. aureus (MICs 0,78-50 µmol.mL-1), mas apenas B. oligolepis demonstrou espectro de ação amplo. O seu fracionamento sequencial, acompanhado de ensaios de inibição do crescimento de S. aureus, gerou frações ativas relativamente homogêneas que, tripsinizadas e os fragmentos trípticos sequenciados, continham metalo-peptidases do tipo III, serino-peptidase ou lectinas do tipo C. A verificação de atividade enzimática e de coagulação sanguínea nessas frações confirmaram as naturezas das proteínas isoladas. Dos três peptídeos amidados (Bo-Ser1, Bo-Met1 e Bo-Lec1) desenhados a partir de suas estruturas, um deles foi ativo frente às leveduras C. albicans, C. krusei e C. parapsilosis (Bo-Met1; MIC de 6,25 - 200 µmol.mL-1). Pela primeira vez, foi demonstrado que: a) os venenos das serpentes peruanas B. barnetti e B. oligolepis apresentam ação antimicrobiana, sendo o último de espectro amplo; b) que as proteínas acima citadas, que incluem uma serino-peptidase, estão envolvidas com essa propriedade do veneno de B. oligolepis; c) que as sequências aminoacídicas e modelo 3D de uma PLA2 ácida e de proteínas presentes nos venenos das serpentes peruanas B. pictus e Bothriopsis oligolepis podem funcionar como fontes naturais para o desenvolvimento de novos AMPs de ação potente em micro-organismos de interesse clínico e científico. / Resistance to antibiotics obtained by pathogenic microorganisms is a global health problem, so the search for new antimicrobial agents has been encouraged. Knowing that many protein fragments and analogues are bioactive peptides, the aim of this work was to develop new antimicrobial peptides (AMPs) based on the amino acid sequences and 3D structures of proteins apparently involved in the antimicrobial activity of snake venoms very little or not studied so far. The first steps taken were: a) selection of a phospholipase A2 (PLA2) present in the venom from a Peruvian Bothrops sp. belonging to the family Viperidae, whose amino acid sequence was known, to model by homology its 3D structure; b) detection of antimicrobial activity in venoms from other Peruvian Viperidae Bothrops and Bothriopsis snakes, selection of an active venom, fractionation of it for isolation of proteins possibly involved in the antimicrobial activity, trypsinization of the isolated proteins, sequencing of the tryptic fragments for protein identification, location of such fragments in the amino acid sequences and 3D structures of proteins directly related in class, function and natural source to the isolated proteins. Then, peptide fragments from the chosen PLA2 (item a) and from the isolated proteins (item b) that presented structural features found in the known AMPs were selected and/or their analogues were designed. Finally, synthesis, purification and characterization of the peptides with AMP potential, (viii) verification on whether or not they display antimicrobial activity. The 3D-structure models of Bothrops pictus PLA2 and four amidated peptides (PLA2-1 to -4) derived from it were obtained, being PLA2-1 active against Gram negative bacteria Escherichia coli and Pseudomonas aeruginosa as well as the yeasts Candida albicans, Candida krusei and Candida parapsilosis (MICs de 6.25-200 µmol.mL-1). Among the three Peruvian snake venoms tested Bothrops taeniatta, Bothrops barnetti and Bothriopsis oligolepis, the last two inhibited the growth of S. aureus (MICs 0.78-50 µmol.mL-1) and B. oligolepis presented a wide spectrum of bacterial action. Sequential fractionation followed by S. aureus growth inhibition assays of the main fractions led to active relatively homogeneous ones. Their trypsinization and sequencing of the tryptic fragments indicated that they contained metalloproteinases type III, serine-proteinase or lectins type CTL. Enzymatic activity and blood coagulation assays confirmed the nature of the isolated proteins. From the three amidated peptides (Bo-Ser1, Bo-Met1 e Bo-Lec1) derived from them, Bo-Met1 showed to be active against C. albicans, C. krusei e C. parapsilosis (MIC 6,25 - 200 µmol.mL-1). In summary, for the first time, it was demonstrated that: a) the venoms of the Peruvian snakes B. barnetti and B. oligolepis display antimicrobial activity, being the last of wide spectrum of action, b) the proteins isolated from B. oligolepis snake venom, including a serine-peptidase, are involved in the antimicrobial activity of the B. oligolepis snake venom, c) the amino acid sequences and 3D structures of acidic PLA2 and of other proteins found in the venoms of the Peruvian B. pictus e Bothriopsis oligolepis snakes can be used as safe and natural sources for the development of new AMPs potent against microorganisms of clinical and scientific interest.

Orientador: Jose Barreto Campello Carvalheira / Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas / Made available in DSpace on 2018-08-25T02:56:20Z (GMT). No. of bitstreams: 1 Mendes_MariaCarolinaSantos_D.pdf: 2658779 bytes, checksum: 153ed5344815e7e59a41c04c4a965670 (MD5) Previous issue date: 2014 / Resumo: A proteína mTOR é um proteína reguladora chave de vários processos celulares, dentre eles proliferação, crescimento e sobrevivência celular. Fatores de crescimento, oxigênio, status energético e a presença de aminoácidos são fundamentais para que todos esses processos ocorram normalmente. Descobertas realizadas nas últimas décadas mostraram que a via da mTOR encontra-se ativada em vários processos celulares, incluindo formação tumoral e angiogênese. A leucina é um aminoácido de cadeia ramificada que tem o maior potencial em ativar a via da mTOR. Devido sua capacidade de promover a síntese proteica e ganho de massa muscular, seu uso é constantemente estimulado em pacientes com câncer. No entanto, seus efeitos no crescimento tumoral não está claro. Dessa forma, realizamos um estudo cujo objetivo principal foi investigar os efeitos da dieta suplementada com leucina na modulação do crescimento tumoral em diferentes linhagens de células tumorais que se diferenciem em relação à ativação constitutiva da via IRS1/Akt/mTOR. Estudos in vivo e in vitro realizados demonstraram que as células que se diferenciam em relação à ativação da via IRS1/AKT/mTOR respondem de maneira distinta à suplementação com leucina. Linhagens de células tumorais que possuem a via da mTOR constitutivamente ativada, PC-3 e MCF-7, quando suplementadas com doses elevadas de leucina in vitro reduziram a proliferação celular e causaram retenção das células na fase G1 do ciclo celular. Já o xenoenxerto tumoral da PC-3 reduziu sua proliferação e aumentou a morte celular quando os animais foram suplementados com leucina na dieta. Nós também observamos aumento da atividade da mTOR e da p70S6K em todas as linhagens celulares quando suplementadas com leucina. O aumento da atividade da proteína mTOR foi acompanhado de redução na fosforilação de AKTser473 nas células que possuíam a via da PI3K hiperativada (PC-3 e MCF-7). Esse fato pode estar ocorrendo devido a ativação das alças de contraregulação ocasionadas pela estimulação excessiva provocada pela suplementação com leucina, naquelas linhagens celulares que já possuem a via hiperativada. Fato este comprovado pelo aumento da fosforilação em serina 307 da proteína IRS1. Dessa forma, nossos resultados sugerem que a ativação da via da mTOR é central para determinar a sensibilidade de tumores à dieta suplementada com leucina, podendo modular o desenvolvimento tumoral naquelas células que já possuem a via IRS1/AKT/mTOR constitutivamente ativada. O mecanismo pelo qual a leucina pode retardar o desenvolvimento tumoral em células que possuem a via da mTOR hiperativada parece estar relacionado com o eixo de regulação negativa p70S6K-PI3K, com consequente redução da fosforilação de AKT e liberação das vias apoptóticas nos tecidos tumorais / Abstract: mTOR is a key regulatory protein in various cellular processes including proliferation, cell growth and survival. Growth factors, oxygen, energy status and amino acids are all essential to these processes. New findings in the last few decades have shown that the mTOR pathway is activated in many cellular processes, including tumorigenesis and angiogenesis. The branched chain amino acid leucine has the greatest potential to activate the mTOR pathway. Due to its ability to promote protein synthesis and muscle mass gain, use of leucine is frequently utilized in patients with cancer. However, the effect of leucine on tumor growth is not clear. The aim of this study is therefore to investigate the effect of diet-supplemented leucine on the modulation of tumor growth in several tumor cell lines that differ in the constitutive activation status of the insulin receptor substrate 1 (IRS1)/AKT/mTOR pathway. Both in vitro and in vivo experiments demonstrated different cell proliferation responses when cells were exposed to high doses of leucine. Tumor cell lines PC-3 and MCF-7, which have a constitutively activated mTOR signaling, displayed reduced cell proliferation and G1 phase cell cycle arrest when supplemented with high doses of leucine in vitro. Likewise, leucine-supplemented PC-3 cell tumor xenografts displayed reduced proliferation and increased cell death. We also observed increased activity of mTOR and its downstream substrate p70S6K in all cell lines supplemented with leucine. Increased mTOR activity was accompanied by a reduction in AKT serine 473 (ser473) phosphorylation in cell lines with a hyperactivated PI3K pathway (PC-3 and MCF-7). This most likely occurred because leucine supplementation further increased mTOR and p70S6K activity, triggering the inhibitory p70S6K/IRS1 axis. In fact, we found increased IRS1 ser307 phosphorylation in hyperactivated cell lines (PC-3 and MCF-7) supplemented with high doses of leucine. Therefore, our results suggest that mTOR pathway activation is central to determining the sensitivity of tumors to leucine supplementation. Furthermore, this could affect the response to leucine-supplemented therapies of those tumors in which the PI3K pathway is constitutively activated. The mechanism for this appears to be related to the negative p70S6K/IRS1 regulation axis, with consequent reduction of AKT phosphorylation and the release of apoptotic pathways in tumor tissues / Doutorado / Fisiopatologia Médica / Doutora em Ciências

Orientadores: Sergio Marangoni, Luis Alberto Ponce Soto / Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-22T22:19:51Z (GMT). No. of bitstreams: 1 VilcaQuispe_Augusto_D.pdf: 3256672 bytes, checksum: 5fbbaf997230230025e7a3945d3d9410 (MD5) Previous issue date: 2013 / Resumo: No presente trabalho duas novas serinoproteases com atividade trombina-simile, nomeadas TLBbz e TLBro isoladas a partir de Bothrops brazili e Bothrops roedingeri respectivamente, foram purificadas em um único passo cromatográfico por HPLC de fase reversa com um alto grau de pureza e homogeneidade molecular, sem perda da atividade biológica. Ambas serinoproteases foram caracterizadas fisico-quimicamente, revelando uma massa molecular relativa de TLBbz = 35,13 KDa e TLBro = 20,24 KDa por SDS-PAGE. Ambas apresentaram atividade proteolítica perante o substrato cromogenico DL-Ba?NA. Os estudos da atividade cinética mostraram que as serinoproteases tiveram um comportamento michaeliano frente ao substrato DL-Ba?NA, apresentando uma Vmax = 1,89 nmoles ?-NA/Lt/min e KM = 0,853 mM para TLBbz; e Vmax = 0,0432 nmoles ?-NA/Lt/min e KM = 0,039 mM para TLBro. Ambas serinoproteases apresentam uma atividade ótima em torno de 38 oC e pH 8,0; sendo inibidas pela ação do fluoreto de fenilmetilsulfonila (PMSF) e outros inibidores, através dos quais a atividade trombina-simile foi reduzida em mais dos 50 % (TLBbz = 86.2 % and TLBro = 42.6 %). Ambas TLBbz e TLBro possuem caráter acido ao apresentar um elevado numero de aminoácidos ácidos, assim como uma boa quantidade em numero de aminoácidos hidrofóbicos, o que garante a estabilidade conformacional da proteína. A presença de 12 cisteinas sugere a possível formação de 6 pontes dissulfeto. TLBbz e TLBro evidenciaram uma atividade fibrinogenolitica frente ao fibrinogenio bovino hidrolisando a cadeia alfa (?) e beta (?), comportando-se como uma trombina-simile tipo AB no caso da TLBro e tipo B, por hidrolizar a cadeia beta (?), no caso da TLBbz. Finalmente, estudos da atividade biológica indicam a propriedade de induzir agregação plaquetaria e esse efeito e inibido pela presença de PMSF / Abstract: In this work, two new serine proteases with thrombin-like activity called TLBbz and TLBro from Bothrops brazili and Bothrops roedingeri respectively were purified in a single chromatographic step by reverse phase HPLC with a high degree of purity and molecular homogeneity without loss of biological activity. Both serine proteases have been characterized physico-chemically, showing a relative molecular mass of TLBbz = 35.13 and TLBro = 20.24 kDa by SDS-PAGE. On the other hand, showed a proteolytic activity towards the chromogenic substrate DL-Ba?NA. The studies of the kinetic activity showed that serine proteases have a michaelian behavior when tested with the substrate DL-Ba?NA, with a Vmax = 1.89 nmoles ?- NA/Lt/min and KM = 0.853 mM for TLBbz, and Vmax = 0.0432 nmoles ?-NA/Lt/min and KM = 0.039 mM for TLBro. Both serine proteases have an optimal activity around 38 °C and pH 8,0; and were inhibited by the action of phenylmethylsulfonyl fluoride (PMSF) and other inhibitors, whereby the thrombin-like activity was reduced in more than 50 % (TLBbz = 86.2 % and TLBro = 42.6 %). Both TLBbz and TLBro have acidic character by presenting a large number of aminoacids acids and a good amount of hydrophobic amino acids, which ensures the conformational stability of the protein. The presence of 12 cysteines suggests the possible formation of six disulfide bridges. TLBbz and TLBro showed a fibrinogenolytic activity against the bovine fibrinogen and hidrolise alpha (?) and beta (?) chain, behaving as a thrombin-like AB types in the case of TLBro and hydrolyzing the beta chain (?) behaving as a thrombin-like B types in the case of TLBbz. Finally, studies of biological activity indicate the ability to induce platelet aggregation and this effect is inhibited by the presence of PMSF / Doutorado / Bioquimica / Doutor em Biologia Funcional e Molecular

Des résultats d’expériences cliniques de reconstruction de l’os maxillaire faites à partir de la greffe d’une "pâte osseuse" gélifiée par l’ajout de facteur tissulaire ont été le primum movens de ce travail. Cette "pâte osseuse", faite d’os en poudre et de plasma enrichi en plaquette (PRP) à laquelle on ajoute du facteur tissulaire, est un modèle à la fois de la coagulation et de la régénération osseuse.<p>Pour analyser des effets de la coagulation, nous avons utilisé un modèle connu :la culture primaire de cellules endothéliales (HUVEC). Les effets in vitro des facteurs de coagulation, dénommés protéases de la coagulation, pris séparément, ont été bien étudiés dans ces cellules, néanmoins aucune information sur l’effet combiné de ces protéases ou du plasma en coagulation n’était connue. Nous avons mesuré la "signalisation calcium" comme réponse cellulaire aux différents agents et ces mesures de la signalisation calcium ont été complétées par la mesure d’une autre réponse biologique, à savoir la sécrétion de cytokines pro-inflammatoires (IL-6 et IL-8). Pour l’étude de la régénération osseuse, la signalisation calcium a été mesurée sur une lignée d’ostéosarcomes humains (SaOS-2), stimulée par des protéases de la voie extrinsèque de la coagulation (facteur VIIa, facteur Xa et thrombine). Comme réponse biologique complémentaire, nous avons évalué l’effet des protéases d’intérêt sur l’apoptose induite par l’absence de sérum dans le milieu de culture.<p>\ / Doctorat en Sciences biomédicales et pharmaceutiques / info:eu-repo/semantics/nonPublished

No description available.

1. Viruses are obligate parasites that hijack the host cell machinery to synthesize their own gene products and for their propagation. In order to establish a successful viral infection, viruses have evolved different strategies to evade host check points. Further more, their success also relies in employing varied strategies to express maximum number of functional proteins from their small constrained genome. Polyprotein processing is a widely used strategy of expression by many plant viruses. With limited information available on this aspect for sobemoviruses, the present study was undertaken. 2. The present thesis deals with the mechanism of Sesbania mosaic virus (SeMV) polyprotein processing and functional characterization of the polyprotein domains. SeMV infects Sesbania grandiflora that belongs to the Fabaceae family. It is a positive sense ssRNA virus with a genome length of 4149 nucleotides. The genome encodes four potential overlapping open reading frames (ORFs). ORF1 codes for an 18 kDa protein that is proposed to be involved in the movement of the virus. ORF 3 codes for the coat protein (CP) that encapsidates the viral genomic RNA to form the viral particles. The central ORF codes for polyprotein that has a serine protease domain at its Nterminus that cleaves the polyprotein at specific E-T/S sites to release the functional domains. So far only in SeMV, the E. coli expressed polyprotein, Protease-VPg-RdRp was shown to undergo processing at E325-T326, E402-T403 and E498-S499 releasing protease, VPg, P10 and RdRp domains respectively. 3. Based on the arrangement of the central ORF, the genome organization of SeMV was earlier shown to be like that of SCPMV type. However, recent sequencing data from the laboratory showed that the organization of SeMV gRNA was like that of CfMV type. This would imply that in SeMV the central two ORFs will be translated to give two polyproteins, 2a (Protease-VPg-C-terminal domain) and 2ab (Protease-VPg-RdRp) the C-terminus of 2a and N-terminus of RdRp being different from what was reported previously. Therefore, in the light of the new genome organization for SeMV, the mechanism of processing of polyprotein 2a and 2ab needs to be revisited. 4. SeMV protease domain was shown to require natively unfolded VPg at its Cterminus for its activity. Aromatic stacking interactions between protease and VPg (via W43 residue) were shown to confer the activity to the protease. However, the residues in the protease domain involved in these interactions have not been identified. 5. The objectives of the present studies are • To elucidate the mechanism of processing of polyproteins 2a and 2ab in E. coli and in planta. • To identify residues in the protease domain involved in mediating aromatic stacking interactions with VPg. • To functionally characterize the C-terminal domain of polyprotein 2a. 6. Polyprotein 2a when expressed in E. coli, from the new cDNA clone, got cleaved at the earlier identified sites E325-T326, E402-T403 and E498-S499 to release protease, VPg, P10 and P8 respectively. The specificities of the cleavage sites were established by mutational analysis. 7. Additionally, a novel cleavage was identified within the protease domain at position E132-S133. The polyprotein 2a that was mutated for this site (ΔN70 2a-E132A) showed no release of P8 protein though the polyprotein was intact for E498-S499 site. Unlike other cleavage site mutants, ΔN70 2a-E132A mutant also revealed large accumulation of intact polyprotein, again implying that the mutation not only abolished the proteolytic cleavage at that site but hampered the processing at other sites. The results confirmed that the cleavage at N-terminus of the protease/polyprotein is crucial for an efficient processing in particular for the cleavage between P10-P8. 8. Interestingly, though the sites in polyprotein 2ab are exactly the same as identified in polyprotein 2a, the former got cleaved between Protease-VPg but not between VPg-RdRp. This cleavage site appeared to be rather masked in polyprotein 2ab. Also, the cleavage at E132-S133 site appeared to be rather slow. These results indicate to a differential cleavage pattern, governed probably by the conformation of 2ab. In other words, the local context of the cleavage site and just not the sequence per se could be playing a key role in 2ab polyprotein processing. 9. Products, corresponding to all cleavages identified in E. coli (E132-S133, E325-T326, E402-T403 and E498-S499) were also detected in infected Sesbania leaves. Products corresponding to the sizes of ΔN132 Protease and ΔN132 Protease-VPg were detected suggesting that the removal of the membrane anchoring domain from the protease does occur in planta. Also, detection of band corresponding P8, confirmed that the cleavage between P10-P8 indeed occured in planta too. 10. The trans cleavage experiments suggested that not all of the four cleavages in polyprotein 2a occur in trans (intermolecular). Cleavages at E132-S133 and E498-S499 do not occur in trans impling that cleavages at these sites could only occur in cis (intramolecular) by auto-proteolysis of the polyprotein. 11. The Thr at P1’ did not make a site trans cleavable. Interestingly, SeMV protease was found to cleave even an E-S site in trans but only when present at positions 324-325 and 402-403, suggesting that trans cleavage in SeMV is governed by the context rather than the Thr at P1’position of the cleavage site. The E498-S499 site was found to be highly stringent not only for the mode of its cleavage (cis cleavage) but also for its sequence (E-S only). A Thr substitution for Ser at this site, made it non cleavable in cis. 12. The results reveal that the polyprotein processing in SeMV is regulated by a number of strategies, viz. a) availability of the cleavage site depending on the conformation of the flanking domains (E132-S133 and E402-T403 cleavages in 2ab). b) Mode of recognition (cis or trans). c) Context/position of the cleavage site. 13. Based on the sequences of all four cleavage sites identified, a consensus has been drawn for SeMV serine protease cleavage site, i.e., N/Q-E-T/S-X (where X is an aliphatic residue) at P2-P1-P1’-P2’ position respectively. 14. With a view to understand the structural reasons for such high specificity, the residues in the S1 and S2 binding pocket, that recognize the substrate P1 and P2 residues respectively, were identified based on the structural comparison of SeMV protease with other Glu/Gln specific proteases. Mutational analysis of these residues clearly demonstrated that H298, T279 and N308 of the S1-binding pocket that would bind the substrate glutamate are crucial for the protease activity. R309 that forms the S2 binding pocket is also crucial for protease activity. 15. Also, the P2 (Asn/Gln) residue recognized by R309 plays an important role in determining the substrate specificity. A positively charged residue Lys was not tolerated at this position. SeMV protease was also shown to efficiently cleave the peptide bond C-terminus to an uncharged Gln in vivo suggesting that it is a Glu/Gln specific protease. 16. An interesting feature of the SeMV protease domain is the presence of a disulphide bond that holds the S1-binding pocket. However, unlike for the cellular counterparts like trypsin, the disulphide was found to be not essential for either the SeMV protease activity or structural stability. 17. Protease and VPg domains were proposed to be involved in aromatic interactions that conferred activity to the protease. The structure of protease revealed a stack of aromatic residues (W271, F269. Y315 and Y319) exposed to the solvent. Mutational analysis was performed to identify their role in mediating the interactions and hence the activity of protease. H275, though not a part of exposed aromatic stack in the protease, was chosen for mutational analysis as it lies close to the W271 in sequence and is conserved in the protease domain across all the known sobemoviruses. The in vivo and trans cleavage assays suggested that residues W271 and H275 but not Y315 or Y319 are crucial for protease activity. 18. The Far-UV CD spectrum of protease-VPg is characterized by a positive peak at 230 nm, signifying the aromatic interactions. Far-UV CD spectral analysis of the aromatic mutants showed that W271 and H275, but not F269 and Y319 are the major contributors of the 230 nm positive peak, confirming the direct involvement of these residues in the stacking interactions with W43 of VPg. Thermal stability studies, fluorescence spectroscopy and 1D-NMR spectroscopy studies also confirmed the histidine aromatic interactions between W271, H275 of protease with W43 of VPg. 19. The loss in aromatic interactions in the mutants caused Protease-VPg to aggregate, suggesting that the aromatic interactions between protease and VPg not only conferred activity to the protease but also the active oligomeric status. 20. In silico analysis of the C-terminal domain showed that it has no significant similarities with any known functional proteins. The region corresponding to P8 was amplified and cloned in pRSET C vector, over-expressed and purified. 21. The purified His-tagged P8 showed mass abnormality on the SDS-PAGE. However, the mass spectrometric analysis of the purified protein showed that it had a molecular mass of 9.766 kDa as is expected for a His-tagged P8. P8 is highly basic, which could possibly explain its anomalous behaviour on the SDS-PAGE. The purified recombinant P8 protein was found to be natively unfolded. In vitro binding studies revealed that P8 had nucleic acid binding property. The protein was also found to be phosphorylated both in vitro and in vivo conditions. 22. Interestingly, P18, (a precursor of P8) but not P8, was found to possess an inherent ATP hydrolyzing property. Optimum conditions for the ATPase assay were found to be Tris HCl pH 8.0, 37 ºC, 5 mM MgCl2. The activity was linear upto 20 mins. P18 could utilize all NTPs and dNTPs. Studies revealed that ATPase activity resided in the P10 domain of P18, though P8 region could enhance the activity. Conclusively, the results demonstrate that the C-terminal domains of polyprotein 2a have ATPase and nucleic acid binding activity and could therefore have possible roles in movement and replication.